The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy

Joanna E. Slusar; Elizabeth A. Cairns; Anna Maria Szczesniak; Heather B. Bradshaw; Adriana Di Polo; Melanie E.M. Kelly

doi:10.1016/j.neuropharm.2013.04.018

The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy

Joanna E. Slusar, Elizabeth A. Cairns, Anna Maria Szczesniak, Heather B. Bradshaw, Adriana Di Polo, Melanie E.M. Kelly

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	116-125
Number of pages	10
Journal	Neuropharmacology
Volume	72
DOIs	https://doi.org/10.1016/j.neuropharm.2013.04.018
Publication status	Published - 2013
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Cellular and Molecular Neuroscience

Access to Document

10.1016/j.neuropharm.2013.04.018

Cite this

@article{bf5a9d1b2b3349a28d25066275a86022,

title = "The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy",

author = "Slusar, {Joanna E.} and Cairns, {Elizabeth A.} and Szczesniak, {Anna Maria} and Bradshaw, {Heather B.} and {Di Polo}, Adriana and Kelly, {Melanie E.M.}",

note = "Funding Information: This study was funded by awards from the Glaucoma Research Foundation of Canada (MEMK) and by a Shaffer Research grant from the Glaucoma Research Foundation (MEMK), and by NIH DA018224 (HBB). JES was funded by a scholarship from the Nova Scotia Health Research Foundation . ",

year = "2013",

doi = "10.1016/j.neuropharm.2013.04.018",

language = "English",

volume = "72",

pages = "116--125",

journal = "Neuropharmacology",

issn = "0028-3908",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy

AU - Slusar, Joanna E.

AU - Cairns, Elizabeth A.

AU - Szczesniak, Anna Maria

AU - Bradshaw, Heather B.

AU - Di Polo, Adriana

AU - Kelly, Melanie E.M.

N1 - Funding Information: This study was funded by awards from the Glaucoma Research Foundation of Canada (MEMK) and by a Shaffer Research grant from the Glaucoma Research Foundation (MEMK), and by NIH DA018224 (HBB). JES was funded by a scholarship from the Nova Scotia Health Research Foundation .

PY - 2013

Y1 - 2013

UR - http://www.scopus.com/inward/record.url?scp=84884864780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884864780&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2013.04.018

DO - 10.1016/j.neuropharm.2013.04.018

M3 - Article

AN - SCOPUS:84884864780

SN - 0028-3908

VL - 72

SP - 116

EP - 125

JO - Neuropharmacology

JF - Neuropharmacology

ER -

The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this